IVA — Inventiva SA Share News
0.000.00%
Last trade - 00:00- €669.85m
- €502.00m
- €4.48m
Brief: Inventiva Secures EUR 50 Million Credit Facility From European Investment Bank
Brief: Inventiva Says FDA Accepted Its IND Application For Phase II Combination Trial LEGEND
Brief: Inventiva FY Revenue Up At EUR 4.2 Mln
Inventiva jumps on 4-mln-euro payment for psoriasis drug trial
Brief: Inventiva Receives A 4 Million Euros Milestone Payment From AbbVie
Brief: Inventiva Announces Positive Results Of Clinical Thorough QT Study Conducted With Lanifibranor
Brief: Inventiva Completes Sale Of $30 Million Through ATM Program
Brief: H.C. Wainwright Raises PT On Inventiva To $40 From $38
Brief: Inventiva Says FDA's Fast Track Designation To Lanifibranor In NASH Encompasses Treatment With Compensated Cirrhosis
Brief: Inventiva H1 Net Operating Loss Widens To 23.6 Million Euros
Brief: Inventiva SA Announces Initiation Of Phase III Clinical Trial Evaluating Lanifibranor In NASH
Brief: Inventiva SA Files For Mixed Shelf Of Upto $300 Million
Brief: Inventiva Reports Implementation Of At-The-Market Program In U.S.
Brief: Inventiva H1 Revenue Rises To EUR 0.2 Mln
Brief: Inventiva: Cash, Cash Equivalents At EUR 107.8 Mln At End-March
Brief: Inventiva End-Dec Cash Position At EUR 113.0 Mln
Brief: Inventiva SA - Major Advances In Nash And Significantly Extended Cash Runway Through Successful IPO In The United States
Brief: Inventiva's Cash Position At End December At 113.0 Million Euros
Brief: Inventiva Announces Design Of Phase III Clinical Trial With Lanifibranor In NASH